- Thinly traded micro cap GenMark Diagnostics (GNMK -26.4%) is off on 30% higher volume, albeit on turnover of only 320K shares, in response to its disclosure in yesterday's earnings call that the European launch of its ePlex System will be delayed until Q1.
- The culprit is an unacceptably high level of variability in the reliability of the tests due to a particular injection molded part in the ePlex cartridge. The ability to manufacture two components which play key roles in the maintenance of reliable cartridge fluidics during operation has apparently been a challenge.